Silexion Therapeutics Corp (SLXN) Form 10-K Annual Reports
Silexion Therapeutics Corp (SLXN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SLXN
CIK: 2022416
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerOmer Gavish
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-05 | 2026-10-05 | DEF 14A | 0001178913-26-004708 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001178913-26-004666 | View SEC Doc Filr Page |
| 424B3 | 2026-09-29 | — | 424B3 | 0001178913-26-004647 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | 8-K | 0001178913-26-004645 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-28 | — | SCHEDULE 13D/A Filing | 0001213900-26-104066 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0001178913-26-004628 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | 8-K | 0001178913-26-004609 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-25 | 2026-09-25 | PRE 14A | 0001178913-26-004606 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | 8-K | 0001178913-26-004604 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-16 | — | DEFA14A | 0001178913-26-004531 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-09 | — | DEFA14A | 0001178913-26-004466 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-24 | 2026-08-24 | DEF 14A | 0001178913-26-004243 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | 8-K | 0001178913-26-004223 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-19 | — | SCHEDULE 13D/A Filing | 0001213900-26-091845 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-18 | — | SCHEDULE 13G Filing | 0001213900-26-091333 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-14 | 2026-08-14 | PRE 14A | 0001178913-26-004145 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001178913-26-004138 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001178913-26-004136 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001178913-26-004128 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001178913-26-004122 | View SEC Doc Filr Page |
| 424B4 | 2026-08-13 | — | 424B4 | 0001178913-26-004116 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088835 | View SEC Doc Filr Page |
| EFFECT | 2026-08-11 | — | EFFECT Filing | 9999999995-26-002627 | View SEC Doc Filr Page |
| S-1/A | 2026-08-10 | — | S-1/A | 0001178913-26-004003 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001178913-26-003966 | View SEC Doc Filr Page |